Another of Pfizer’s Braftovi regimens has shown benefit in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. Patients in cohort three of the Phase III BREAKWATER trial (NCT04607421) received a combination of …

Moderna’s recent FDA whiplash has dealt vaccinemakers a difficult question: What will become of a highly regulated industry faced with unpredictable directives? The FDA last week refused to review Moderna’s application for an mRNA-based flu vaccine, saying …

By Joe Graedon, M.S., and Teresa Graedon, Ph.D. King Features Syndicate Q. My husband got COVID-19 last fall. He has had great success with Paxlovid in the past, when he got it for free during the pandemic. This time, he was charged $800 on his Medicare …

Delray Beach, FL, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The global Respiratory Syncytial Virus (RSV) vaccines market is entering a critical phase of maturation and strategic realignment, with valuation projected to reach $1.24 billion by 2030, declining from $ …

… Trade (DPIIT), the Department of Pharmaceuticals (DoP), NITI Aayog, and MSINS … of Pharmaceuticals, NITI Aayog, the Ministry of Health & Family Welfare, Pfizer … and a global leader in pharmaceuticals and healthtech by 2047 requires …

Completed clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events and no viral rebounds with equivalent time to sustained symptom resolution; results were recapitulated in PAXLOVID®-ineligible patients, …

Cold and Flu Supplements Market growing at 10.7% CAGR through 2031, fueled by vitamin C, zinc demand and year-round immune wellness adoption. AUSTIN, TX, UNITED STATES, February 19, 2026 /⁨EINPresswire.com⁩/ -- According to DataM Intelligence, the …

The Global Organ-on-a-Chip Market is estimated to be valued at USD 155.3 Mn in 2025 and is expected to reach USD 1,211.1 Mn by 2032. BURLINGAME, CA, UNITED STATES, February 19, 2026 /⁨EINPresswire.com⁩/ -- The Global Business Landscape is being …

PI3K Inhibitor Drug Class Market (2026-2033) | Targeted Therapy, CAGR, and Key Players AUSTIN, TX, UNITED STATES, February 19, 2026 /⁨EINPresswire.com⁩/ -- Market Size and Outlook (2026) According to DataM Intelligence, the Global PI3K …

Female patients with moderate-to-severe aortic regurgitation (AR) exhibit worse survival during medical management due to lower mortality thresholds for left ventricular end-systolic volume index (LVESVi) in women than in men, according to a recent study.1 …